The granting of a patent for Collplant Biotechnologies' dermal filler product candidate could potentially increase the company's competitive advantage in the aesthetics market. This is because the patent protection could prevent competitors from copying their product, thus potentially leading to increased sales and profits for the company. Therefore, this news could potentially have a positive impact on the company's stock price in the short term.